News
Trademark activity surged across major markets in 2024 | Swiss pharma ranks among top foreign portfolios in US, UK and EU | ...
7 April 2025 Miami-based hire brings experience in patent litigation and portfolio management, having previously worked on ...
Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on ...
Court partially overturns PTAB decision favouring Broad Institute in the long-running gene-editing patent dispute | Case sent ...
16 July 2024 UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by ...
New addition from ArentFox Schiff brings expertise in consumer electronics, semiconductors, software, and pharmaceuticals. If ...
Counsel are using their unique position as the centre of science and law to deliver value far beyond traditional IP ...
Smaller US companies can now choose to take on much larger, foreign opponents at the ITC, explain Cristen Corry, Paul Ainsworth and Uma Everett of Sterne Kessler.
Industry body says agreement doesn’t address ‘longstanding industry concerns’ about IP | Deal criticised for ‘lack of detail’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results